Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Safety and Efficacy of NVXT Solution in Patients With Mild-to-Moderate Fungal Infection of the Toe Nail
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2020
Price :
$35
*
At a glance
- Drugs NP 213 (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 31 Mar 2020 According to NovaBiotics media release, based on the results of this study and three more studies, an article has been published and will will appear in the next issue of Medical Mycology, the official journal of the International Society for Human and Animal Mycology.
- 31 Mar 2020 Results published in the NovaBiotics Media Release
- 19 Apr 2016 Status changed from active, no longer recruiting to completed.